| For: | Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746 [PMID: 16521187 DOI: 10.3748/wjg.v12.i5.739] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm |
| Number | Citing Articles |
| 1 |
Hao Wu, Peng Liu, Siming Gong, Xiaoming Liu, Michael A. Hill, Zhenguo Liu, Meihua Xu, Canxia Xu. Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization study. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01128-0
|
| 2 |
T. M. McCann, A. E. Ridyard, R. W. Else, J. W. Simpson. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease. Journal of Small Animal Practice 2007; 48(11): 620 doi: 10.1111/j.1748-5827.2007.00335.x
|
| 3 |
Javier P. Gisbert, Yago González-Lama, José Maté. 5-Aminosalicylates and renal function in inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(5): 629 doi: 10.1002/ibd.20099
|
| 4 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
|
| 5 |
Olga Yu. Barysheva, Ruslan N. Simanov. The relationship between inflammatory bowel diseases and kidney diseases. HERALD of North-Western State Medical University named after I.I. Mechnikov 2022; 14(1): 31 doi: 10.17816/mechnikov105170
|
| 6 |
Caroline Kerner, James D. Lewis, Mark T. Osterman. Medical Therapy of Ulcerative Colitis. 2014; : 297 doi: 10.1007/978-1-4939-1677-1_27
|
| 7 |
Monique M. Elseviers, Marc E. De Broe. Clinical Nephrotoxins. 2008; : 399 doi: 10.1007/978-0-387-84843-3_17
|
| 8 |
Javier P. Gisbert, Marta Luna, Yago González-Lama, Inés D. Pousa, Marta Velasco, Ricardo Moreno-Otero, José Maté. Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study. Gastroenterología y Hepatología 2008; 31(8): 477 doi: 10.1157/13127088
|
| 9 |
Stavros A. Doumas, Christos Tsironis, Abdul-Adl Bolaji, Panagiotis Garantziotis, Eleni Frangou. Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction. Autoimmunity Reviews 2023; 22(6): 103327 doi: 10.1016/j.autrev.2023.103327
|
| 10 |
Juliana Yang, Aalam Sohal, Vikash Kumar, Jasraj Kahlon, Diksha Mahendru, Tejasvini Khanna, Anmol Singh. Insights into renal and urological complications of inflammatory bowel disease. World Journal of Nephrology 2024; 13(3): 96574 doi: 10.5527/wjn.v13.i3.96574
|
| 11 |
Domenico Corica, Claudio Romano. Renal Involvement in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 2016; 10(2): 226 doi: 10.1093/ecco-jcc/jjv138
|
| 12 |
Emily Joyce, Paulina Glasner, Sarangarajan Ranganathan, Agnieszka Swiatecka-Urban. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatric Nephrology 2017; 32(4): 577 doi: 10.1007/s00467-016-3394-5
|
| 13 |
Еxtraintestinal manifestations of inflammatory bowel disease. Actual problems of modern medicine 2020; (5) doi: 10.26565/2617-409X-2020-5-08
|
| 14 |
Konstantinos Oikonomou, Andreas Kapsoritakis, Theodoros Eleftheriadis, Ioannis Stefanidis, Spiros Potamianos. Renal manifestations and complications of inflammatory bowel disease. Inflammatory Bowel Diseases 2011; 17(4): 1034 doi: 10.1002/ibd.21468
|
| 15 |
Mathilde Treffel, Jacqueline Champigneulle, Fleuria Meibody, Emmanuelle Laurain, Luc Frimat, Hélène Busby-Venner. Néphrite tubulo-interstitielle et maladie de Crohn, néphrotoxicité ou atteinte extradigestive de la maladie de Crohn ? À propos d’un cas. Néphrologie & Thérapeutique 2019; 15(1): 59 doi: 10.1016/j.nephro.2018.07.406
|
| 16 |
Kamil Strzelak, Jagoda Misztal, Łukasz Tymecki, Robert Koncki. Bianalyte multicommutated flow analysis system for microproteinuria diagnostics. Talanta 2016; 148: 707 doi: 10.1016/j.talanta.2015.04.021
|
| 17 |
Akihiro Shimizu, Nobuo Tsuboi, Saeko Hatanaka, Shohei Fukunaga, Takaya Sasaki, Kotaro Haruhara, Masahiro Okabe, Shinya Yokote, Hiroyuki Ueda, Yuko Iwashita, Kan Uchiyama, Masato Ikeda, Takashi Yokoo. Distinct clinicopathological features of IgA nephropathy associated with Crohn’s disease: comparison with ulcerative colitis and non-IBD IgA nephropathy. Clinical and Experimental Nephrology 2026; doi: 10.1007/s10157-026-02850-9
|
| 18 |
Nimisha Sarah Mathew, Serva Peddha Muthukumar, Bheemanakere Kempaiah Bettadaiah, Pradeep Singh Negi. Efficacy of a functional food ingredient fromEnsete superbumRoxb. Cheesman peel in reducing the severity of ulcerative colitis in a murine model. Food & Function 2022; 13(6): 3732 doi: 10.1039/D1FO03365D
|
| 19 |
Mahmoud Mosli, Abdulrahman M Alzahrani, Rafeef A Bahafzalla, Tala A Gazzaz, Rahaf M Slaghour , Ghidah Z Altabsh, Sarah B Aljadani , Razan N Alturkestani , Sondos S Hussein , Abdullah Kashgary, Omar I Saadah. Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia. Cureus 2021; doi: 10.7759/cureus.15787
|
| 20 |
Lucas Guillo, Ferdinando D'Amico, Hamza Achit, Carole Ayav, Francis Guillemin, Silvio Danese, Luc Frimat, Laurent Peyrin-Biroulet. Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know. Digestive and Liver Disease 2021; 53(6): 691 doi: 10.1016/j.dld.2021.01.015
|
| 21 |
Kawthar Braysh, Alice Gerges Geagea, Charbel Matar, Manfredi Rizzo, Assaad Eid, Liliane Massaad-Massade, Samir Mallat, Abdo Jurjus. Kidney Manifestations of Inflammatory Bowel Diseases. Open Journal of Gastroenterology 2018; 8(05): 172 doi: 10.4236/ojgas.2018.85020
|
| 22 |
S Boulajaad, M Haida, Ait Errami, S Oubaha, Z Samlani, K Krati. Association of ulcerative colitis and IgA nephropathy: A case report. Global Journal of Medical and Clinical Case Reports 2021; 8(3): 105 doi: 10.17352/2455-5282.000140
|
| 23 |
Zhihui Yang, Xiaochang Xu, Yejing Dong, Yimin Zhang. The pathological and outcome characteristics of renal lesions in Crohn’s disease. BMC Nephrology 2022; 23(1) doi: 10.1186/s12882-022-02883-8
|
| 24 |
Christian Primas, Gottfried Novacek, Karin Schweiger, Andreas Mayer, Alexander Eser, Pavol Papay, Cornelia Gratzer, Sieglinde Angelberger, Clemens Dejaco, Walter Reinisch, Harald Vogelsang. Renal insufficiency in IBD — Prevalence and possible pathogenetic aspects. Journal of Crohn's and Colitis 2013; 7(12): e630 doi: 10.1016/j.crohns.2013.05.001
|
| 25 |
Sana Chams, Reina Badran, Skye El Sayegh, Nour Chams, Ali Shams, Inaya Hajj Hussein. Inflammatory bowel disease: Looking beyond the tract. International Journal of Immunopathology and Pharmacology 2019; 33 doi: 10.1177/2058738419866567
|
| 26 |
Claudia Ott, Jürgen Schölmerich. Extraintestinal manifestations and complications in IBD. Nature Reviews Gastroenterology & Hepatology 2013; 10(10): 585 doi: 10.1038/nrgastro.2013.117
|
| 27 |
Adrian Covic, Liviu Segall, Adrian Covic. Oxford Textbook of Clinical Nephrology. 2015; : 726 doi: 10.1093/med/9780199592548.003.0093_update_001
|
